New Delhi: The Bharatiya Janata Party has asked India’s film industry ‘Bollywood’ to repudiate whatever links it has with ISI, Pakistan’s spy agency, reacting to viral social media pictures of few eminent personalities of B-town with anti-India activists abroad. Also Read: 'Dil Bechara' The Last Ever Film Of Sushant Singh Rajput To Premiere Tomorrow | Know All About It

BJP vice-president Baijayant Panda on Wednesday took note of the tweets glutting the social media and urged Bollywood celebs to renounce their links to Pakistanis & NRI’s with track record of fueling violence and separatism in Jammu and Kashmir.

"Came across shocking threads documenting personal & business links of some Bollywood personalities with certain Pakistanis & NRIs with undeniable track record encouraging violence in J&K, who have verifiable links to ISI & Pak army. I urge patriotic Bollywoodies to renounce them,” he said in his tweet.


Though Panda abstained from naming any Bollywood celebrity, he urged 'patriotic Bollywoodies' to stop working with these people.

What’s the controversy about?

The controversy erupted after pictures of Bollywood’s superstar Shahrukh Khan and his wife Gauri Khan with Kashmiri separatist Tony Ashai emerged on social media. It is pertinent to note that Tony Ashai who also goes by the name Aziz Ashai, has been instrumental in urging Kashmiri youth to fight against India.

Also Read: I Lost 7 To 8 Films After Accidentally Injuring Amitabh Bachchan On Coolie Set, Says Puneet Issar

A popular Srinagar-based activist who goes by the name Al iskandar @TheSkandar on Twitter posted a series of tweets claiming that Tony Ashai, also known as Aziz Ashai, has been a member of the terror group Jammu & Kashmir Liberation Front (JKLF) sponsored by ISI.




Also check out these stories: 

EX Bigg Boss Contestant Jasleen Matharu Finds Love In Bhopal-Based Surgeon, Anup Jalota Plays Cupid

Rajasthan Politics: Disqualification Proceedings Against Pilot Camp Or Not? SC Hearing On Speaker's Power Today

Coronavirus Vaccine Cannot Be Expected Before 2021, Says WHO Expert Amid High Hopes From Oxford Trial